OLD National Bancorp IN lessened its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 13.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 59,933 shares of the company's stock after selling 9,356 shares during the period. OLD National Bancorp IN's holdings in Procter & Gamble were worth $10,380,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also added to or reduced their stakes in PG. Cardano Risk Management B.V. boosted its holdings in shares of Procter & Gamble by 10.6% in the 1st quarter. Cardano Risk Management B.V. now owns 807,042 shares of the company's stock valued at $130,943,000 after purchasing an additional 77,051 shares in the last quarter. First Affirmative Financial Network grew its stake in Procter & Gamble by 2.2% in the first quarter. First Affirmative Financial Network now owns 6,034 shares of the company's stock valued at $979,000 after acquiring an additional 129 shares during the period. Meyer Handelman Co. boosted its stake in Procter & Gamble by 0.5% during the 1st quarter. Meyer Handelman Co. now owns 565,266 shares of the company's stock valued at $91,714,000 after purchasing an additional 2,604 shares during the last quarter. Gulf International Bank UK Ltd raised its holdings in shares of Procter & Gamble by 1.9% in the first quarter. Gulf International Bank UK Ltd now owns 209,068 shares of the company's stock valued at $33,921,000 after purchasing an additional 3,958 shares during the last quarter. Finally, Rockland Trust Co. boosted its stake in shares of Procter & Gamble by 6.6% in the 1st quarter. Rockland Trust Co. now owns 208,658 shares of the company's stock worth $33,855,000 after buying an additional 12,937 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Insider Buying and Selling
In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the business's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company's stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now owns 21,513 shares of the company's stock, valued at $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 383,194 shares of company stock worth $65,140,718. Insiders own 0.17% of the company's stock.
Procter & Gamble Stock Performance
NYSE:PG traded up $0.01 during mid-day trading on Friday, hitting $171.28. 8,372,536 shares of the company traded hands, compared to its average volume of 6,692,838. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The firm has a market cap of $404.24 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41. The stock's fifty day moving average price is $171.77 and its 200-day moving average price is $167.24. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble's revenue for the quarter was down .6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.83 EPS. Research analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 65.69%.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on PG shares. Barclays lowered shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. DA Davidson reissued a "neutral" rating and issued a $159.00 price target on shares of Procter & Gamble in a report on Tuesday, October 15th. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a "hold" rating in a research report on Monday, July 22nd. Jefferies Financial Group downgraded Procter & Gamble from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Finally, StockNews.com cut shares of Procter & Gamble from a "buy" rating to a "hold" rating in a research report on Thursday, August 1st. Nine equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average price target of $176.21.
Read Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Profile
(
Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
